KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Sophiris Bio Stock and on which exchange is it traded?
The symbol for Sophiris Bio is SPHS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sophiris Bio Stock?
Sophiris Bio holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Sophiris Bio Stock?
Sophiris Bio Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sophiris Bio Stock.

What's the current price of Sophiris Bio Stock?
As of the end of day on the May 27, 2022, the price of an Sophiris Bio (SPHS) share was $0.0001.

What is the 52-week high and low for Sophiris Bio Stock?
The 52-week high for Sophiris Bio Stock is $0.0300 and the 52-week low is $0.000001.
Click to get the best stock tips daily for free!

About Sophiris Bio

Sophiris Bio Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company’s primary product candidate is PRX302, which is in Phase III clinical trial for treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. It has a strategic relationship with Kissei Pha... SPHS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT